Related Experiment Video
Updated: Jun 24, 2025

08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
13.9K
Suicide attempt during ramelteon addition to flunitrazepam: A case report
1Department of Neuropsychiatry Oita University Faculty of Medicine Yufu Oita Japan.
PCN Reports : Psychiatry and Clinical Neurosciences
|June 13, 2024
Summary
Flunitrazepam and ramelteon combination may increase suicide risk in susceptible individuals. Discontinuation of ramelteon led to rapid symptom resolution, suggesting a link to the drug combination.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Psychiatry
Background:
- Benzodiazepines, like flunitrazepam, are associated with disinhibition, potentially causing aggression, impulsivity, self-harm, and suicide attempts.
- Ramelteon is generally considered less likely to cause disinhibition.
Observation:
- A case study involving a 43-year-old female with primary insomnia is presented.
- Flunitrazepam monotherapy did not elicit disinhibition.
- The co-administration of ramelteon with flunitrazepam resulted in disinhibition, characterized by aggressiveness and culminating in a suicide attempt.
Findings:
- The patient's disinhibition and aggressive behavior resolved rapidly upon discontinuation of ramelteon.
- This suggests a potential synergistic effect between ramelteon and flunitrazepam in inducing disinhibition in certain individuals.
Implications:
- The combination of ramelteon and flunitrazepam may pose a risk for suicide attempts in susceptible patients.
- Clinicians should exercise caution when prescribing this combination, particularly in patients with a history of psychiatric distress.
- Further research is warranted to elucidate the mechanisms underlying this interaction and identify at-risk populations.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
REM Sleep Behavior Disorder
180
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
180
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Sleepwalking and Sleep Talking
142
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
142
CNS Depressants: Barbiturates and Benzodiazepines
249
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
249

